Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05950334 |
| Title | FT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Fate Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Karmanos Cancer Center | RECRUITING | Detroit | Michigan | 48201 | United States | Details |
| University of Minnesota Masonic Cancer Center | RECRUITING | Minneapolis | Minnesota | 55455 | United States | Details |
| University of Nebraska Medical Center | RECRUITING | Omaha | Nebraska | 68198 | United States | Details |
| OU Health Stephenson Cancer Center | RECRUITING | Oklahoma City | Oklahoma | 73104 | United States | Details |
| Tennessee Oncology | RECRUITING | Nashville | Tennessee | 37203 | United States | Details |
| Baylor Houston Methodist Hospital | RECRUITING | Houston | Texas | 77030 | United States | Details |